title: Prostate cancer in 2016: Improved outcomes and precision medicine come within reach.
authors.affiliation: San Camillo and Forlanini Hospitals, Medical Oncology, Pavilion Flajani 1, Circonvallazione Gianicolense 87, Rome 00152, Italy.
authors.forename: Cora N
authors.initials: CN
authors.lastname: Sternberg
authors.affiliation: Weill Cornell Medical College, Division of Medical Oncology, 525 East 68th Street, Box 403, New York 10021, USA.
authors.forename: Himisha
authors.initials: H
authors.lastname: Beltran
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood / Q000235:genetics*; D002986:Clinical Trials as Topic / Q000379:methods; D018095:Germ-Line Mutation / Q000235:genetics*; D006801:Humans; D008297:Male; D057285:Precision Medicine / Q000379:methods* / Q000639:trends; D017430:Prostate-Specific Antigen / Q000097:blood / Q000235:genetics; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen